These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 23203765)

  • 1. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.
    Marie I; Josse S; Hatron PY; Dominique S; Hachulla E; Janvresse A; Cherin P; Mouthon L; Vittecoq O; Menard JF; Jouen F
    Arthritis Care Res (Hoboken); 2013 May; 65(5):800-8. PubMed ID: 23203765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
    Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
    Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies.
    Tomonaga M; Sakamoto N; Ishimatsu Y; Kakugawa T; Harada T; Nakashima S; Hara A; Hara S; Horai Y; Kawakami A; Mukae H; Kohno S
    Lung; 2015 Feb; 193(1):79-83. PubMed ID: 25394672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
    Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
    Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
    La Corte R; Lo Mo Naco A; Locaputo A; Dolzani F; Trotta F
    Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
    Richards TJ; Eggebeen A; Gibson K; Yousem S; Fuhrman C; Gochuico BR; Fertig N; Oddis CV; Kaminski N; Rosas IO; Ascherman DP
    Arthritis Rheum; 2009 Jul; 60(7):2183-92. PubMed ID: 19565490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.
    Tillie-Leblond I; Wislez M; Valeyre D; Crestani B; Rabbat A; Israel-Biet D; Humbert M; Couderc LJ; Wallaert B; Cadranel J
    Thorax; 2008 Jan; 63(1):53-9. PubMed ID: 17557770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
    Jiang M; Dong X; Zheng Y
    Medicine (Baltimore); 2021 May; 100(19):e25816. PubMed ID: 34106621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
    Zheng WJ; Wei W; Tang FL
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
    Yang H; Chen Q; Sun C; Jin Q; Zhang L; Liu Q; Peng Q; Wang G; Lu X
    Respir Res; 2024 May; 25(1):222. PubMed ID: 38811943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
    Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
    Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
    J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
    Häussermann A; Gillissen A; Seidel W
    Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of interstitial pneumonia with anti-Jo-1 antibodies in the absence of myositis].
    Kinebuchi S; Mizuno K; Moriyama H; Ooi H; Hasegawa T; Yoshizawa H; Suzuki E; Gejyo F
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):739-45. PubMed ID: 14584396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
    Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
    J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options in anti-jo-1 antisynthetase syndrome with interstitial lung disease: comment on the article by Marie et al.
    Cavagna L; Caporali R
    Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1548. PubMed ID: 23554341
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
    Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
    Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.